Day Lila
 All days

Thursday, 30 July 2026

Canada calls off its strongest trade weapon before it fires

12 stories · 12 beats

12 editions

Biotech

MapLight's schizophrenia drug hit its main goal and lost two-thirds of its value the same morning, Lilly posted huge weight-loss numbers with murkier heart data, and an FDA panel rejected a Duchenne therapy - three trials this week judged less on whether an effect was real than on how big it was.